[HTML][HTML] Child and adolescent obesity
The prevalence of child and adolescent obesity has plateaued at high levels in most high-
income countries and is increasing in many low-income and middle-income countries …
income countries and is increasing in many low-income and middle-income countries …
[HTML][HTML] GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives
R Nevola, R Epifani, S Imbriani, G Tortorella… - International Journal of …, 2023 - mdpi.com
To date, non-alcoholic fatty liver disease (NAFLD) is the most frequent liver disease,
affecting up to 70% of patients with diabetes. Currently, there are no specific drugs available …
affecting up to 70% of patients with diabetes. Currently, there are no specific drugs available …
[HTML][HTML] Comparing scientific abstracts generated by ChatGPT to real abstracts with detectors and blinded human reviewers
Large language models such as ChatGPT can produce increasingly realistic text, with
unknown information on the accuracy and integrity of using these models in scientific writing …
unknown information on the accuracy and integrity of using these models in scientific writing …
Comparing scientific abstracts generated by ChatGPT to original abstracts using an artificial intelligence output detector, plagiarism detector, and blinded human …
Background Large language models such as ChatGPT can produce increasingly realistic
text, with unknown information on the accuracy and integrity of using these models in …
text, with unknown information on the accuracy and integrity of using these models in …
New insights into the treatment of obesity
Obesity is a chronic, progressive and relapsing disease with a rising global prevalence
associated with increased morbidity and mortality and reduced quality of life. Treatment of …
associated with increased morbidity and mortality and reduced quality of life. Treatment of …
Gut hormone co-agonists for the treatment of obesity: from bench to bedside
The discovery and development of so-called gut hormone co-agonists as a new class of
drugs for the treatment of diabetes and obesity is considered a transformative breakthrough …
drugs for the treatment of diabetes and obesity is considered a transformative breakthrough …
[HTML][HTML] Adolescent PCOS: a postpubertal central obesity syndrome
L Ibáñez, F de Zegher - Trends in Molecular Medicine, 2023 - cell.com
Adolescent polycystic ovary syndrome (PCOS) is a highly prevalent, reversible, endocrine-
metabolic mode essentially driven by ectopic fat, which, in turn, often results from a …
metabolic mode essentially driven by ectopic fat, which, in turn, often results from a …
[HTML][HTML] Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials
MS Popoviciu, L Păduraru, G Yahya… - International journal of …, 2023 - mdpi.com
Obesity is a chronic disease with high prevalence and associated comorbidities, making it a
growing global concern. These comorbidities include type 2 diabetes, hypertension …
growing global concern. These comorbidities include type 2 diabetes, hypertension …
Prevention of cardiorenal complications in people with type 2 diabetes and obesity
DJ Drucker - Cell Metabolism, 2024 - cell.com
Traditional approaches to prevention of the complications of type 2 diabetes (T2D) and
obesity have focused on reduction of blood glucose and body weight. The development of …
obesity have focused on reduction of blood glucose and body weight. The development of …
Obesity in adolescents
TS Hannon, SA Arslanian - New England Journal of Medicine, 2023 - Mass Medical Soc
Key Clinical Points Obesity in Adolescents Adolescent patients with obesity benefit from
evaluation and follow-up according to a long-term care model with attention to and …
evaluation and follow-up according to a long-term care model with attention to and …